HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection

AIDS. 2002 May 3;16(7):1071-3. doi: 10.1097/00002030-200205030-00015.

Abstract

We have previously shown that Vpu is rarely targeted by HIV-1-specific cytotoxic T lymphocytes (CTL). The present report extends these findings and describes the characterization of the first CTL epitope within HIV-1 Vpu, identified in an individual with long-term non-progressive HIV-1 infection. The epitope was shown to be highly conserved among HIV clade B sequences and is restricted by HLA-A*3303, an HLA allele commonly seen in Asian and west-African populations.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Consensus Sequence
  • Cytotoxicity, Immunologic
  • Disease Progression
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV Long-Term Survivors
  • HIV-1 / immunology*
  • HLA-A Antigens / immunology*
  • Human Immunodeficiency Virus Proteins
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / immunology*
  • T-Lymphocytes, Cytotoxic / immunology*
  • Viral Regulatory and Accessory Proteins / immunology*

Substances

  • HLA-A Antigens
  • HLA-A*33 antigen
  • Human Immunodeficiency Virus Proteins
  • Peptide Fragments
  • Viral Regulatory and Accessory Proteins
  • vpu protein, Human immunodeficiency virus 1